Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Alan Campbell currently holds 697,550 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Alan Campbell has been a net seller of JANX stock. They have purchased $0 and sold $1.3M worth of shares.
David Alan Campbell's most recent insider trade was on Jul 8, 2026, when they sold 7,000 shares at $0.00 per share.
David Alan Campbell serves as Executive at Janux Therapeutics, Inc. (JANX). They have executed 9 insider transactions totaling $1.3M over their tenure at the company.
David Alan Campbell holds the position of Executive at Janux Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
David Alan Campbell has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Alan Campbell was on Sep 27, 2024, when they sold $873.7K worth of JANX shares. This transaction involved 18,957 shares at $46.09 per share.
David Alan Campbell currently owns 697,550 shares of Janux Therapeutics, Inc. (JANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Alan Campbell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Alan Campbell has 9 Form 4 filings on record as an insider at Janux Therapeutics, Inc..
Set alerts for David Alan Campbell and 40,000+ other insiders.